… B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide can be used to
indicate heart failure, as increased levels of B-type natriuretic peptide and N-terminal pro-B-type …

Aims The coronavirus disease 2019 (COVID‐19) pandemic has created significant
challenges to healthcare globally, necessitating rapid restructuring of service provision. This …

Patients are ultimately the end-users of medical therapies and need to be actively integrated
as contributors and decision-makers in the process of product development throughout …

Aims Heart failure (HF) is associated with comorbidities which independently influence
treatment response and outcomes. This retrospective observational study (January 2020–June …

Heart failure (HF) is common and costly. 1 Around 26 million people are living with HF globally,
and a substantial proportion of healthcare budgets is spent on HF services. 2 Large trials …

Aims Heart failure (HF) has a lower public profile compared with other serious health
conditions, notably cancer. This discourse analysis study investigates the extent to which HF is …

Introduction Expansion in digital health using mobile phone health applications has increased
recently. We developed a mobile phone application (Aintree Heart Failure Passport-AHFP …

Background: Ten percent of patients diagnosed with pancreatic cancer undergo
pancreaticoduodenectomy. It is known that these patients have unmet psychological support needs, …

Objectives 64 million people are currently affected by Heart Failure (HF). Core symptoms of
HF include shortness of breath, fatigue and fluid retention, which can have a great impact on …

Aims Heart failure (HF) is associated with multiple co-morbidities which independently
influence response to treatment as well as outcomes. This retrospective observational study (…